Keyphrases
Knowledge Gaps
100%
Hypereosinophilic Syndrome
100%
Knowledge Controversy
100%
Eosinophils
22%
Disease Progression
11%
Targeted Therapy
11%
Treatment Options
11%
Commercially Available
11%
Immunosuppressive Drugs
11%
Clinical Manifestations
11%
Cytotoxic Drugs
11%
Eosinophilia
11%
Corticosteroids
11%
Heterogeneous Groups
11%
Blood Eosinophilia
11%
Clinical Subtypes
11%
Imatinib
11%
Hypereosinophilia
11%
Incomplete Response
11%
Biological Treatment
11%
Tissue Eosinophilia
11%
Mepolizumab
11%
Biologic Failure
11%
Medicine and Dentistry
Biological Product
100%
Hypereosinophilic Syndrome
100%
Eosinophil
22%
Eosinophilia
22%
Disease Exacerbation
11%
Imatinib
11%
Hypereosinophilia
11%
Targeted Therapy
11%
Disease
11%
Immunosuppressive Drug
11%
Mepolizumab
11%
Cytotoxic Agent
11%